中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/23 | 3,430 | 3,509 | 3,422 | 3,473 | +75 | +2.2% | 2,275,600 |
| 2022/06/22 | 3,383 | 3,423 | 3,355 | 3,398 | +59 | +1.8% | 1,974,400 |
| 2022/06/21 | 3,359 | 3,381 | 3,321 | 3,339 | +25 | +0.8% | 2,220,100 |
| 2022/06/20 | 3,345 | 3,357 | 3,290 | 3,314 | +3 | +0.1% | 1,892,600 |
| 2022/06/17 | 3,276 | 3,328 | 3,258 | 3,311 | -57 | -1.7% | 2,747,200 |
| 2022/06/16 | 3,437 | 3,439 | 3,368 | 3,368 | -12 | -0.4% | 2,012,300 |
| 2022/06/15 | 3,446 | 3,450 | 3,373 | 3,380 | -79 | -2.3% | 2,449,600 |
| 2022/06/14 | 3,500 | 3,520 | 3,422 | 3,459 | -95 | -2.7% | 2,272,200 |
| 2022/06/13 | 3,557 | 3,577 | 3,530 | 3,554 | -54 | -1.5% | 1,947,800 |
| 2022/06/10 | 3,618 | 3,647 | 3,565 | 3,608 | -58 | -1.6% | 2,620,200 |
| 2022/06/09 | 3,631 | 3,676 | 3,626 | 3,666 | +36 | +1% | 2,179,300 |
| 2022/06/08 | 3,569 | 3,633 | 3,566 | 3,630 | +114 | +3.2% | 2,326,500 |
| 2022/06/07 | 3,521 | 3,544 | 3,497 | 3,516 | -26 | -0.7% | 1,560,900 |
| 2022/06/06 | 3,491 | 3,566 | 3,488 | 3,542 | +45 | +1.3% | 1,864,600 |
| 2022/06/03 | 3,519 | 3,525 | 3,481 | 3,497 | -4 | -0.1% | 1,961,500 |
| 2022/06/02 | 3,539 | 3,546 | 3,473 | 3,501 | -49 | -1.4% | 1,677,900 |
| 2022/06/01 | 3,521 | 3,576 | 3,519 | 3,550 | +22 | +0.6% | 1,929,500 |
| 2022/05/31 | 3,528 | 3,568 | 3,468 | 3,528 | +14 | +0.4% | 7,075,300 |
| 2022/05/30 | 3,493 | 3,542 | 3,475 | 3,514 | +85 | +2.5% | 4,039,600 |
| 2022/05/27 | 3,473 | 3,475 | 3,402 | 3,429 | -16 | -0.5% | 2,401,800 |
| 2022/05/26 | 3,500 | 3,533 | 3,441 | 3,445 | -62 | -1.8% | 2,184,100 |
| 2022/05/25 | 3,555 | 3,565 | 3,504 | 3,507 | -44 | -1.2% | 1,878,100 |
| 2022/05/24 | 3,587 | 3,604 | 3,548 | 3,551 | -62 | -1.7% | 2,018,900 |
| 2022/05/23 | 3,580 | 3,614 | 3,555 | 3,613 | +77 | +2.2% | 1,581,800 |
| 2022/05/20 | 3,550 | 3,577 | 3,527 | 3,536 | +11 | +0.3% | 1,931,400 |
| 2022/05/19 | 3,555 | 3,605 | 3,516 | 3,525 | -104 | -2.9% | 2,966,800 |
| 2022/05/18 | 3,584 | 3,646 | 3,565 | 3,629 | +93 | +2.6% | 2,491,800 |
| 2022/05/17 | 3,584 | 3,592 | 3,532 | 3,536 | -30 | -0.8% | 2,170,500 |
| 2022/05/16 | 3,650 | 3,659 | 3,566 | 3,566 | -25 | -0.7% | 1,611,400 |
| 2022/05/13 | 3,579 | 3,625 | 3,557 | 3,591 | +40 | +1.1% | 2,086,000 |
| 2022/05/12 | 3,648 | 3,665 | 3,546 | 3,551 | -166 | -4.5% | 2,479,400 |
| 2022/05/11 | 3,702 | 3,761 | 3,701 | 3,717 | ±0 | ±0% | 1,765,500 |
| 2022/05/10 | 3,685 | 3,738 | 3,652 | 3,717 | +21 | +0.6% | 1,784,000 |
| 2022/05/09 | 3,793 | 3,818 | 3,691 | 3,696 | -148 | -3.9% | 2,501,600 |
| 2022/05/06 | 3,841 | 3,865 | 3,741 | 3,844 | -27 | -0.7% | 2,760,200 |
| 2022/05/02 | 3,900 | 3,900 | 3,846 | 3,871 | -32 | -0.8% | 2,012,000 |
| 2022/04/28 | 3,948 | 3,948 | 3,848 | 3,903 | -3 | -0.1% | 3,104,400 |
| 2022/04/27 | 3,825 | 3,919 | 3,792 | 3,906 | +46 | +1.2% | 4,684,600 |
| 2022/04/26 | 3,995 | 4,027 | 3,811 | 3,860 | -262 | -6.4% | 4,120,600 |
| 2022/04/25 | 4,135 | 4,150 | 4,096 | 4,122 | -19 | -0.5% | 1,918,300 |
| 2022/04/22 | 4,188 | 4,196 | 4,108 | 4,141 | -57 | -1.4% | 1,459,200 |
| 2022/04/21 | 4,227 | 4,239 | 4,150 | 4,198 | -17 | -0.4% | 2,188,500 |
| 2022/04/20 | 4,182 | 4,252 | 4,161 | 4,215 | +38 | +0.9% | 1,872,900 |
| 2022/04/19 | 4,174 | 4,215 | 4,152 | 4,177 | -19 | -0.5% | 1,379,100 |
| 2022/04/18 | 4,242 | 4,246 | 4,148 | 4,196 | -68 | -1.6% | 1,034,100 |
| 2022/04/15 | 4,230 | 4,294 | 4,188 | 4,264 | -27 | -0.6% | 1,512,400 |
| 2022/04/14 | 4,297 | 4,320 | 4,267 | 4,291 | +35 | +0.8% | 1,921,400 |
| 2022/04/13 | 4,135 | 4,268 | 4,135 | 4,256 | +103 | +2.5% | 3,066,000 |
| 2022/04/12 | 4,175 | 4,227 | 4,136 | 4,153 | -35 | -0.8% | 1,825,600 |
| 2022/04/11 | 4,147 | 4,192 | 4,130 | 4,188 | +1 | ±0% | 1,793,700 |
701～
750
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
